Advocacy for Equity Around Evidence-Based Treatments: Overview and Proceedings of the AMERSA 2023 Conference

Megan Buresh, Bradley M. Buchheit, Kristin Wason, Rebecca Northup, Jeffrey Bratberg, Deborah S. Finnell

Research output: Contribution to journalComment/debatepeer-review

Abstract

This commentary provides an overview of the 2023 Association of Multidisciplinary Education and Research in Substance use and Addiction (AMERSA) annual conference: Advocacy for Equity Around Evidence-Based Treatments, held from November 1 to 4, 2023, in Washington, DC. The conference featured 9 interactive workshops, 106 oral abstract presentations, and 130 posters. From the preconference workshop to plenary sessions, paper, and poster presentations, there was a focus on addressing imbalanced social systems and structures underlying disparities. In the face of increasing drug overdose deaths, diminished access to prevention, intervention, treatment, and recovery supports for racial and ethnic minorities, there is a pressing need for advocacy for equity around evidence-based treatments.

Original languageEnglish (US)
Pages (from-to)156-162
Number of pages7
JournalSubstance Use and Addiction Journal
Volume45
Issue number2
DOIs
StatePublished - Apr 2024

Keywords

  • advocacy
  • drug overdose
  • equity
  • ethnic minorities
  • racial
  • substance use
  • treatment

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Advocacy for Equity Around Evidence-Based Treatments: Overview and Proceedings of the AMERSA 2023 Conference'. Together they form a unique fingerprint.

Cite this